Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rang in aandelen #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aandeelprijs
$36.75
Laatst gesynchroniseerd: 2026-08-27
Marktkapitalisatie
$1.63B
Verandering (1 dag)
-0.78%
Verandering (1 jaar)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Categorie

Dividendrendementgeschiedenis voor Avalyn Pharma Inc. Common Stock (AVLN)
Het dividendrendement (TTM) van Avalyn Pharma Inc. Common Stock (aandelsymbool: AVLN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Avalyn Pharma Inc. Common Stock (AVLN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH